Salvia officinalis (Sage) leaf extract as add-on to statin therapy in hypercholesterolemic type 2 diabetic patients: A randomized clinical trial

International Journal of Molecular and Cellular Medicine

Volumn 5, Issue 3, 2016, Pages 141-148

  Kianbakht, Saeed ^a   Nabati, Farzaneh ^a   Abasi, Behrooz ^b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b Diabetes Clinic   (Iran)

Author keywords

Diabetes mellitus; Dyslipidemia; Salvia officinalis; Statin

Indexed keywords

EID: 85021905030     PISSN: 22519637     EISSN: 22519645     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Brietzke SA. Oral antihyperglycemic treatment options for type 2 diabetes mellitus. Med Clin North Am 2015;99:87-106.
2. Taskinen MR, Boren J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis 2015;239:483-95.
3. Frank ML, Gerhardt AM. Treating dyslipidemia in patients with type 2 diabetes mellitus. Nurse Pract 2015;40:18-22; quiz -3.
4. Halcox J, Misra A. Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat? Metab Syndr Relat Disord 2015;13:1-21.
5. Kones R, Rumana U. Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional Therapies. Drugs 2015;75:1187-99.
6. Kones R, Rumana U. Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 2015;75:1201-28.
7. Sando KR, Knight M. Nonstatin therapies for management of dyslipidemia: a review. Clin Ther 2015;37:2153-79.
8. Sikand G, Kris-Etherton P, Boulos NM. Impact of functional foods on prevention of cardiovascular disease and diabetes. Curr Cardiol Rep 2015;17:39.
9. Liu HJ, Zhang CY, Song F, et al. A novel partial agonist of peroxisome proliferator-activated receptor gamma with excellent effect on insulin resistance and type 2 diabetes. J Pharmacol Exp Ther 2015;353:573-81.
10. Fukuda K, Matsumura T, Senokuchi T, et al. Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-gamma activation. Biochem Biophys Res Commun 2015;457:23-30.
11. Fleming T. PDR for Herbal Medicines. 4th ed. New York: Medical Economics Company; 2015.
12. Rau O, Wurglics M, Paulke A, et al. Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med 2006;72:881-7.
13. Christensen KB, Jorgensen M, Kotowska D, et al. Activation of the nuclear receptor PPARgamma by metabolites isolated from sage (Salvia officinalis L.). J Ethnopharmacol 2010;132:127-33.
14. Ninomiya K, Matsuda H, Shimoda H, et al. Carnosic acid, a new class of lipid absorption inhibitor from sage. Bioorg Med Chem Lett 2004;14:1943-6.
15. Moradabadi L, Montasser Kouhsari S, Fehresti Sani M. Hypoglycemic effects of three medicinal plants in experimental diabetes: inhibition of rat intestinal alpha-glucosidase and enhanced pancreatic insulin and cardiac Glut-4 mRNAs expression. Iran J Pharm Res 2013;12:387-97.
16. Oboh G, Henle T. Antioxidant and inhibitory effects of aqueous extracts of Salvia officinalis leaves on pro-oxidantinduced lipid peroxidation in brain and liver in vitro. J Med Food 2009;12:77-84.
17. Oniga I, Parvu AE, Toiu A, et al. Effects of Salvia officinalis L. extract on experimental acute inflammation. Rev Med Chir Soc Med Nat Iasi 2007;111:290-4.
18. Eidi M, Eidi A, Zamanizadeh H. Effect of Salvia officinalis L. leaves on serum glucose and insulin in healthy and streptozotocin-induced diabetic rats. J Ethnopharmacol 2005;100:310-3.
19. Lima CF, Azevedo MF, Araujo R, et al. Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? Br J Nutr 2006;96:326-33.
20. Sa CM, Ramos AA, Azevedo MF, et al. Sage tea drinking improves lipid profile and antioxidant defences in humans. Int J Mol Sci 2009;10:3937-50.
21. Kianbakht S, Abasi B, Perham M, et al. Antihyperlipidemic effects of Salvia officinalis L. leaf extract in patients with hyperlipidemia: a randomized double-blind placebo-controlled clinical trial. Phytother Res 2011;25:1849-53.
22. Kianbakht S, Dabaghian FH. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial. Complement Ther Med 2013;21:441-6.
23. Behradmanesh S, Derees F, Rafieian-Kopaei M. Effect of Salvia officinalis on diabetic patients. J Renal Inj Prev 2013;2:51-4.
24. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J Diabetes 2015;6:456-80.
25. Han J, Weng X, Bi K. Antioxidants from a Chinese medicinal herb -Lithospermum erythrorhizon. Food Chemistry 2008;106:2-10.
26. Gutfinger T. Polyphenols in olive oils. Journal of the American Oil Chemists Society 1981;58:966-8.
27. Yoo KM, Lee CH, Lee H, et al. Relative antioxidant and cytoprotective activities of common herbs. Food Chemistry 2008;106:929-36.
28. Verma N, Trehan N. HPLC analysis of methanolic extract of herbs for quercetin content. J Pharmacog Phytochem 2013;2:159-62.